Table 1.
Difference in PDW ratio according to clinical characteristics in ESCC patients.
| Variables | Cases | ||
|---|---|---|---|
| N | % | ||
| Sex | Male | 428 | 86.5 |
| Female | 67 | 13.5 | |
| Age at therapy initiation(years) | Median | 62 | |
| Interquartile range | (55–67) | ||
| Pathology grade | Well differentiated | 38 | 7.8 |
| middle differentiated | 326 | 67.1 | |
| Poorly differentiated | 121 | 24.9 | |
| Undifferentiated | 1 | 0.02 | |
| Depth of tumor | T1a–1b | 51 | 10.3 |
| T2 | 100 | 20.2 | |
| T3 | 344 | 69.5 | |
| Lymph node metastasis | N0 | 231 | 46.7 |
| N1 | 165 | 33.3 | |
| N2 | 74 | 14.9 | |
| N3 | 25 | 5.1 | |
| Pathological stage | 1a–1b | 91 | 18.4 |
| 2a–2b | 181 | 36.6 | |
| 3a–3c | 223 | 45.1 | |
| Vessel invasive | Yes | 138 | 27.9 |
| No | 357 | 72.1 | |
| Nerve infiltration | Yes | 169 | 34.1 |
| No | 326 | 65.9 | |
| Treatment regimen | S | 339 | 68.5 |
| S plus postoperative C | 111 | 22.4 | |
| S plus postoperative CRT | 45 | 9.1 | |
| Hospital time after operation(days) | Median | 11 | |
| Interquartile range | (10–13) | ||
| PDW | Median | 13.2 | |
| Interquartile range | (11.7–15.0) | ||
| Platelet | Median | 198.5 | |
| Interquartile range | (160.0–236.0) | ||
| Albumin | Median | 42.1 | |
| Interquartile range | (39.5–44.2) | ||
| RDW | Median | 12.8 | |
| Interquartile range | (12.3–13.3) | ||
| Aspartate transaminase | Median | 22 | |
| Interquartile range | (19.0–27.0) | ||
| Fibrinogen | Median | 3.73 | |
| Interquartile range | 3.19–4.34 | ||
| Hemoglobin | Median | 13.7 | |
| Interquartile range | (12.7–14.6) | ||
Abbreviations: S, surgery; C, chemotherapy; CRT, chemoradiotherapy; PDW, platelet distribution width; RDW, red cell distribution width.